Aplicación de MTA para tratamientos de pulpotomías en pacientes pediátricos. Revisión sistemática.

Abstract

Introduction: MTA is a material that is currently presented as a great alternative for the Pediatric Dentist in pulp treatments, its use is justified by its great biocompatibility, microbial capacity, for not showing toxicity, for contributing to a good seal and removing the original tissue when it is attached to the pulp and periradicular tissues. The Mineral Trioxide Aggregate (MTA) was initially reported in 1993 by Torabinejad et al., at the University of Loma Linda (California), in 1995 and it was patent by Torabinejad and White. Purpose: The objective of the study was to determine the application of MTA for pulpotomy treatments in pediatric patients. Materials and methods: The present work belongs to a qualitative, retrospective and descriptive research, 39 scientific articles were analyzed. Results: The purpose of this study was to determine the application of the MTA types (commercial house) for pulpotomy treatments in pediatric patients. To evaluate this study, we consider the variables of presentation of the product, type of materials, according to its composition and according to its setting time to be able to analyze the evolution that the MTA has had since it was created until today. Discussion: Several authors consider that the most current materials are better for pediatric clinical care because most of these try to make the attention time shorter. Conclusion: We can conclude that, when studying different scientific articles, Mineral Trioxide Aggregate (MTA) is a very effective material for the treatment of pulpotomy when we have caries with pulp involvement.